FDA Gearing Up To Standardize Clinical Trial Results In Labeling
FDA is gearing up to review and standardize the way that clinical trial results are reported in labeling
You may also be interested in...
FDA is preparing to issue its final guidance on patient-reported outcomes soon - which will codify the agency's approach to validating PROs used as clinical endpoints - but a recent workshop made clear that there is still a substantial amount of work to be done on identifying and creating appropriate measurements of patient-, clinician- and caregiver-reported outcomes
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011